DANZEL

This brand name is authorized in Nigeria.

Active ingredients

The drug DANZEL contains one active pharmaceutical ingredient (API):

1	Albendazole UNII F4216019LN - ALBENDAZOLE
	Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.
	Read more about Albendazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-1504	Tablet	DANZEL 200 TABLETS TAB 200 mg 1 X 2	53 CMS-PP-346856 DANZEL 200 TABLETS ALBENDAZOLE 200MG EACH UNCOATED CHEWABLE TABLET CONTAINS ALBENDAZOLE USP 200MG EXCIPIENTS carnauba wax, hypromellose, lactose monohydrate, magnesium stearate B4-1504 Drugs Imported Products 1X2 Over The Counter (OTC) 7/27/2023 SUITELIFE PHARMACEUTICALS LTD, 4 ayo davis close off ekolonu street, surulere, lagos 8129419809 suitelifepharma@yahoo.com JASH PHARMA PVT. LTD., Plot No.-143/144, Surat special Economic Zone, Near Sachin Railway Station, Sachin - 394230, Surat, Gujarat, India., India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P02CA03	Albendazole	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-1504